Patrick N Harter

15PUBLICATIONS
70CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Haematological tumoursEpigenetics (incl. genome methylation and epigenomics)Molecular targetsNeurogenetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 16, 2026
Interlaboratory performance testing on EPIC v2.0 CNS tumor profiling demonstrates high reproducibility of tumor classification but reveals the need for harmonized copy number variation reporting.

|Mar 17, 2026
Clinical Manifestations of Primary CNS T-Cell Lymphoma: A Retrospective Study of Histopathologic, Molecular, and Neuroimaging Features.

Katharina Johanna Müller, Philipp Karschnia, Leon D Kaulen

|Aug 26, 2024
Survival probability of epigenetically defined IDH-wild-type glioblastoma without necrosis or vascular proliferation.

Patrick N Harter, Katharina J Weber, Franz L Ricklefs

|Jun 04, 2024
Disturbance in cerebral blood microcirculation and hypoxic-ischemic microenvironment are associated with the development of brain metastasis.

Jenny Roesler, Daniel Spitzer, Xiaoxiong Jia

|Apr 28, 2023
Correction to: Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes.

Lucas Hoffmann, Roland Coras, Katja Kobow

|Mar 27, 2023
Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes.

Lucas Hoffmann, Roland Coras, Katja Kobow

Pageof 3

Frequent Collaborators

6 joint publications

Michael W Ronellenfitsch

2 joint publications

Benedikt Sauer

2 joint publications

Costin Leu

2 joint publications

Javier A López-Rivera